16
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Clinical Characteristics and Treatment Outcome Between Localized and Disseminated Nocardiosis in a Tertiary Hospital in China

, ORCID Icon, , , , , , , & show all
Pages 2379-2387 | Received 09 Feb 2024, Accepted 06 Jun 2024, Published online: 13 Jun 2024

References

  • Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012;87(4):403–407. doi:10.1016/j.mayocp.2011.11.016
  • Mehta HH, Shamoo Y. Pathogenic Nocardia: a diverse genus of emerging pathogens or just poorly recognized? PLoS Pathog. 2020;16(3):e1008280. doi:10.1371/journal.ppat.1008280
  • Tremblay J, Thibert L, Alarie I, Valiquette L, Pépin J. Nocardiosis in Quebec, Canada, 1988–2008. Clin Microbiol Infect. 2011;17(5):690–696. doi:10.1111/j.1469-0691.2010.03306.x
  • Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41(10):4497–4501. doi:10.1128/JCM.41.10.4497-4501.2003
  • Cattaneo C, Antoniazzi F, Caira M, et al. Nocardia spp infections among hematological patients: results of a retrospective multicenter study. Int J Infect Dis. 2013;17(8):e610–614. doi:10.1016/j.ijid.2013.01.013
  • Zhao P, Zhang X, Du P, Li G, Li L, Li Z. Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay. Sci Rep. 2017;7:43660. doi:10.1038/srep43660
  • Yasuike M, Nishiki I, Iwasaki Y, et al. Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: the first reference genome sequence of the fish pathogenic Nocardia species. PLoS One. 2017;12(3):e0173198. doi:10.1371/journal.pone.0173198
  • Brown-Elliott BA, Biehle J, Conville PS, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol. 2012;50(3):670–672. doi:10.1128/JCM.06243-11
  • Restrepo A, Clark NM. Nocardia infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation. Clin Transplant. 2019;33(9):e13509. doi:10.1111/ctr.13509
  • Soueges S, Bouiller K, Botelho-Nevers E, et al. Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study. J Infect. 2022;85(2):130–136. doi:10.1016/j.jinf.2022.05.029
  • Dumitrascu AG, Rojas CA, Stancampiano F, et al. Invasive nocardiosis versus colonization at a tertiary care center: clinical and radiological characteristics. Mayo Clin Proc Innov Qual Outcomes. 2023;7(1):20–30. doi:10.1016/j.mayocpiqo.2022.11.002
  • Yetmar ZA, Challener DW, Seville MT, Bosch W, Beam E. Outcomes of nocardiosis and treatment of disseminated infection in solid organ transplant recipients. Transplantation. 2023;107(3):782–791. doi:10.1097/TP.0000000000004343
  • Lucas SB, Hounnou A, Peacock C, Beaumel A, Kadio A, De Cock KM. Nocardiosis in HIV-positive patients: an autopsy study in West Africa. Tuber Lung Dis. 1994;75(4):301–307. doi:10.1016/0962-8479(94)90137-6
  • Meena DS, Kumar D, Bohra GK, Midha N, Garg MK. Clinical characteristics and treatment outcome of central nervous system nocardiosis: a systematic review of reported cases. Med Princ Pract. 2022;31(4):333–341. doi:10.1159/000525509
  • Margalit I, Lebeaux D, Tishler O, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021;27(4):550–558. doi:10.1016/j.cmi.2020.12.019
  • Ramos ESM, Lopes RS, Trope BM. Cutaneous nocardiosis: a great imitator. Clin Dermatol. 2020;38(2):152–159. doi:10.1016/j.clindermatol.2019.10.009
  • Wang H, Zhu Y, Cui Q, et al. Epidemiology and antimicrobial resistance profiles of the nocardia species in China, 2009 to 2021. Microbiol Spectr. 2022;10(2):e0156021. doi:10.1128/spectrum.01560-21
  • Li J, Shen H, Yu T, et al. Isolation and characterization of nocardia species from pulmonary nocardiosis in a tertiary hospital in China. Jpn J Infect Dis. 2022;75(1):31–35. doi:10.7883/yoken.JJID.2020.1096
  • Beucler N, Farah K, Choucha A, et al. Nocardia farcinica cerebral abscess: a systematic review of treatment strategies. Neurochirurgie. 2022;68(1):94–101. doi:10.1016/j.neuchi.2021.04.022
  • Budzik JM, Hosseini M, Mackinnon AC Jr, Taxy JB. Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt). 2012;13(3):163–170. doi:10.1089/sur.2011.012
  • Traxler RM, Bell ME, Lasker B, Headd B, Shieh WJ, McQuiston JR. Updated Review on Nocardia Species: 2006–2021. Clin Microbiol Rev. 2022;35(4):e0002721. doi:10.1128/cmr.00027-21
  • Burke VE, Lopez FA. Approach to skin and soft tissue infections in non-HIV immunocompromised hosts. Curr Opin Infect Dis. 2017;30(4):354–363. doi:10.1097/QCO.0000000000000378
  • Ercibengoa M, Càmara J, Tubau F, et al. A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016. Int J Infect Dis. 2020;90:161–166. doi:10.1016/j.ijid.2019.10.032
  • Nso N, Nassar M, Guzman Perez LM, Shaukat T, Trandafirescu T. Localized pulmonary nocardia farcinica infection as the presenting symptom of acquired immunodeficiency syndrome. Cureus. 2021;13(8):e17611. doi:10.7759/cureus.17611
  • Kogure M, Takase E, Fusamoto A, et al. Treatment of refractory localized pulmonary nocardiosis caused by Nocardia mexicana with a combination of medication and surgery. Respirol Case Rep. 2023;11(3):e01098. doi:10.1002/rcr2.1098